Neurological disorders and neuro oncology impose a growing clinical and societal burden, while therapeutic development remains slow, costly, and uncertain.

Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

People communicate with each other, sometimes face to face, sometimes with a text message or phone call. Cells also ...

In this edition of the biotech bi-weekly, catch up on five innovative product launches – from lab balances to spatial solutions – and recent partnerships driving human health forward. Illumina (CA, ...

Abstract: Spatial transcriptomics enables the study of gene expression within the spatial context of tissues, offering valuable insights into tissue organization and function. However, technical ...

By analyzing brain tissue at single-cell resolution, researchers identified biological pathways that separate Alzheimer’s ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of ...

A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.

Recent advances in single-cell biology, spatial transcriptomics, multi-omics integration, artificial intelligence, and biosensor engineering are ...

Muna Therapeutics, a clinical-stage biotechnology company pioneering a new era of drug discovery for neurodegenerative ...

A novel spatial transcriptomics atlas developed by Northwestern Medicine scientists may improve the understanding of niche cellular interactions in the gastrointestinal tract that promote the ...